Add Feeds
Publisher Windows
Streaming Headlines
Streaming Windows

Log out

Social Connect

OR Log into your Account below
Want One? Create New Account
Email:
Password:
Trending Immunotherapy news Share your news. Contact Us!
All
BioInsights
Cancer Research Institute
Conversation, The
Endpoints News
FierceBiotech
Immune Regulation News
Immuno-Oncology News
Immunotherapy China
Immunotherapy News
Medical News Today
Nature
News Medical
OncLive
Oncology Central
pharmaphorum
Scientist, The
STAT
Technology Networks
Volume 9.23 | Jun 23
1 HR AGO - De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation
Exosomes Offer Significant Potential in Detecting and Treating Disease
8 HRS AGO - Exosomes - tiny biological nanoparticles which transfer information between cells - offer Expand
In defense of Medicare’s annual wellness exam
11 HRS AGO - Medicare's free annual wellness visits give primary care physicians much-needed time to talk with Expand
FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies
12 HRS AGO - Oncomine Dx Target Test returns results in days, helping physicians rapidly develop treatment Expand
Generon’s A-337 Antibody Is Entering Phase 1 Trial as Treatment for Solid Tumors
1 DAY AGO - The A-337 antibody that Generon Corporation developed to sic immune-system T-cells on cancer cells Expand
Researchers find new evidence that autoimmunity plays role in Parkinson's disease
1 DAY AGO - Researchers have found the first direct evidence that autoimmunity- in which the immune system Expand
Targeting Nrp1 may help improve immunotherapy
2 DAYS AGO - Researchers at the University of Pittsburgh (PA, USA) have discovered that targeting regulatory Expand
$40 million backs Gamida’s breakthrough umbilical cord blood therapy
2 DAYS AGO - Jerusalem based Gamida Cell has closed their latest financing round with $40 million of new Expand
Could DNA barcoding be the key to detecting cancer earlier?
2 DAYS AGO - Researchers have developed an innovative technique to detect tumor DNA in blood with a greater Expand
Ilixadencel Provokes Strong Response Against Kidney Cancer, Phase 1/2 Clinical Trial Shows
5 HRS AGO - Injecting ilixadencel into the tumors of newly diagnosed metastatic kidney cancer patients Expand
Advancing immunotherapy for high-risk neuroblastoma patients: an interview with Juliet Gray
10 HRS AGO - The European Commission has recently approved dinutuximab beta for high risk neuroblastoma Expand
Pediatric disease designation for Fibrocell’s scelorderma candidate
12 HRS AGO - Fibrocell’s scleroderma gene therapy has been granted Rare Pediatric Disease Designation by the Expand
New ethical lapses alleged in controversial India cervical cancer screening trial
13 HRS AGO - A long-debated study aimed at validating a low-cost way to screen for cervical cancer in India has Expand
Grappling with cancers that break all the rules
1 DAY AGO - A renewed focus on glioblastoma and other tough-to-treat cancers that break all the rules could Expand
CRUK launches next phase of cancer ‘Grand Challenge’
1 DAY AGO - CRUK launches next phase of cancer ‘Grand Challenge’ June 22, 2017 Charity launches second set of Expand
Landmark FDA approval bolsters personalized medicine
2 DAYS AGO - The FDA's approval of a cancer drug based on the cancer's biomarkers, rather than its location in Expand
TET enzymes as oxygen-dependent tumor suppressors: exciting new avenues for cancer management
2 DAYS AGO - TET-activating strategies represent an exciting new avenue for cancer management, find out more in Expand
Scientists step closer to drug treatment for hepatitis B
2 DAYS AGO - A major new insight into how hepatitis B virus works could pave the way for new drug treatments Expand
Frontline Pembrolizumab Approval Leaves Questions for Later Lines in Bladder Cancer
5 HRS AGO - Jorge Garcia, MD, discusses how the field of bladder cancer has transformed with the FDA approval Expand
Conference report: Oxford Global’s 2nd Annual Advances in Immuno-Oncology Congress
11 HRS AGO - Did you attend the 2nd Annual Advances in Immuno-Oncology Congress this year? In this conference Expand
Genentech’s subcutaneous rituximab approved in US
22 HRS AGO - Genentech’s subcutaneous rituximab approved in US June 23, 2017 Subcutaneous version gives more Expand
Scientists develop new algorithm to decipher how immune system recognizes and binds antigens
1 DAY AGO - Scientists from St. Jude Children's Research Hospital and Fred Hutchinson Cancer Research Center Expand
Nivolumab/Ipilimumab Combo Active in Sarcoma
2 DAYS AGO - Dual checkpoint inhibition with nivolumab (Opdivo) plus ipilimumab (Yervoy) induced an objective Expand
Acceleron Discontinues Development of Dalantercept for Advanced Renal Cell Carcinoma Therapy
2 DAYS AGO - The DART Phase 2 clinical trial, assessing Acceleron Pharma’s dalantercept in combination Expand
Immunotherapy for prostate cancer: What you need to know
2 DAYS AGO - Immunotherapy is an emerging treatment for cancer that aims to boost the immune system cells' Expand

Immunotherapy News

Our Latest Blogs

24/04/2017

Press Release: Parker Institute researchers publish first major scientific paper in Nature

  Parker Institute researchers publish first major
24/04/2017

Genentech: BEYOND THE CYCLE

  MAR 31, 2017   The pace at which cancer
06/03/2017

Immune Checkpoint Modulator Clinical Combinations

Are you fully up-to-date on the most rational combination
06/03/2017

Post event ICI Boston report

Check out this report to gain a comprehensive insight into some of
13/02/2017

Interview with the CEO of Medcision

With Valentines Day just around the corner we wanted to show you
13/02/2017

Neoantigen Survey Results

Over the past month we conducted a survey to find out the
09/02/2017

Welcome to Immunotherapy News!

Immunotherapy News is the ultimate curated news site for the global

About Immunotherapy News
All the latest Immunotherapy news, all in one place. The best immunotherapy news sources, immunotherapy blogs, immunotherapy video channels, podcasts and social media chat for the Immunotherapy community. Curated and brought to you by Hanson Wade.
Contact Us
Follow Us